TYRA Tyra Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TYRA

Price (delayed)

$23.23

Market cap

$1.39B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.39

Enterprise value

$1.32B

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 44
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5
Highlights
The debt has declined by 7% year-on-year and by 2% since the previous quarter
Tyra Biosciences's equity has increased by 17% YoY but it has decreased by 9% QoQ
TYRA's net income is down by 40% YoY and by 13% QoQ
The EPS has declined by 34% year-on-year and by 10% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://tyra.bio
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of TYRA

TYRA stock price

How has the Tyra Biosciences stock price performed over time
Intraday
-9.15%
1 week
-4.6%
1 month
-10.83%
1 year
82.48%
YTD
-11.64%
QTD
-27.27%

Financial performance

How have Tyra Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$160.46M
Net income
-$148.57M
Gross margin
N/A
Net margin
N/A
TYRA's net income is down by 40% YoY and by 13% QoQ
The operating income has contracted by 32% YoY and by 12% from the previous quarter

Price vs fundamentals

How does TYRA's price correlate with its fundamentals

Growth

What is Tyra Biosciences's growth rate over time

Valuation

What is Tyra Biosciences stock price valuation
P/E
N/A
P/B
3.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 34% year-on-year and by 10% since the previous quarter
The P/B is 65% above the 5-year quarterly average of 2.6 but 9% below the last 4 quarters average of 4.7
Tyra Biosciences's equity has increased by 17% YoY but it has decreased by 9% QoQ

Efficiency

How efficient is Tyra Biosciences business performance
The ROE has contracted by 46% YoY and by 9% from the previous quarter
The ROA has contracted by 44% YoY and by 8% from the previous quarter
The return on invested capital has declined by 34% year-on-year and by 5% since the previous quarter

Dividends

What is TYRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TYRA.

Financial health

How did Tyra Biosciences financials performed over time
TYRA's total liabilities has surged by 53% year-on-year and by 21% since the previous quarter
Tyra Biosciences's quick ratio has decreased by 33% YoY and by 28% from the previous quarter
The debt is 98% smaller than the equity
The debt to equity has surged by 100% since the previous quarter
Tyra Biosciences's equity has increased by 17% YoY but it has decreased by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.